Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia von Iastrebner, M, Lazzarino, C, Nucifora, E, Penchasky, D, Fernandez, I, Gusmao Moreno, B.G.M, Rivas, M.M, Espinosa, D, Abello Polo, V, Boada, M, Enrico, A, Araujo Schuster, S, Agra, M, Sarmiento, M, Flores, G, Alfonso, G, Crisp, R, Gusmao Moreno, B, Consortium, I

Volltext

101 - Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia von Iastrebner, M., Lazzarino, C., Nucifora, E., Penchasky, D., Fernandez, I., Gusmao Moreno, B.G.M., Rivas, M.M., Espinosa, D., Abello Polo, V., Boada, M., Enrico, A., Araujo Schuster, S., Agra, M., Sarmiento, M., Flores, G., Alfonso, G., Crisp, R., Gusmao Moreno, B., Consortium, I.

Volltext